deltatrials
Completed NCT00399321

A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Sponsor: Susan G. Komen Breast Cancer Foundation

Conditions Breast Cancer Postmenopausal Bone Loss
Updated 11 times since 2017 Last updated: Jul 3, 2017 Started: Apr 30, 2006 Primary completion: Sep 30, 2010 Completion: Sep 30, 2010

This observational or N/A phase trial investigates Breast Cancer and Postmenopausal Bone Loss and is currently completed. Susan G. Komen Breast Cancer Foundation leads this study, which shows 11 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 6 earlier versions

  1. Feb 2019 — Nov 2020 [monthly]

    Completed

  2. Jun 2018 — Feb 2019 [monthly]

    Completed

  3. May 2018 — Jun 2018 [monthly]

    Completed

  4. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  5. Aug 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  6. Jan 2017 — Aug 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Susan G. Komen Breast Cancer Foundation
  • University of Michigan Rogel Cancer Center
Data source: University of Michigan Rogel Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ann Arbor, United States